About Jedd Levine
Form D filings for Revere Pharmaceuticals from 2019 to 2023 list Jedd Levine as executive officer and director.
Jedd Levine first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Jedd Levine in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jedd Levine works with at each company, as listed on that company's latest Form D.
Revere Pharmaceuticals Inc. · Form D, Jun 12, 2023
KP
Kollol Pal
Director
ML
Marc Lippman
Director
IS
Ian Silverman
President and Chief Executive Officer, director